Turning Point Brands, Inc. Q3 2025 Earnings Recap

TPB Q3 2025 November 6, 2025

Get alerts when TPB reports next quarter

Turning Point Brands delivered strong Q3 results, achieving a 31% revenue growth and increasing adjusted EBITDA guidance, underscored by exceptional performance in the Modern Oral segment.

Earnings Per Share Beat

$1.05 vs $0.81 est.

+29.6% surprise

Revenue Miss

118979000 vs 120424360 est.

-1.2% surprise

Market Reaction

1-Day -0.96%

5-Day -0.66%

30-Day -2.06%

See TPB alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue rose to $119 million, with Modern Oral contributing $36.7 million, including $1.5 million in slotting fees.
Adjusted EBITDA increased 17% to $31.3 million; full-year guidance raised to $115 million-$120 million.
Nicotine pouch sales guidance updated to $125 million-$130 million, reflecting robust demand and strategic market penetration.
White nicotine pouch sales surged 628% year-over-year, with ALP expanding into retail channels ahead of schedule.
Significant investments are being made in sales force, marketing, and production capabilities to capitalize on the anticipated $10 billion nicotine category.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit TPB on AllInvestView.

Next Q1 2026